Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceHeart & metabolic

Hesperidin

Hesperidin is the main flavanone in oranges and the junior partner in most vein formulas. Taken alone, its cardiometabolic effects are small and inconsistent between meta-analyses, and its absorption depends entirely on your gut bacteria.

What the science says

  • Effects on lipids and blood pressure are small at best, and meta-analyses disagree Limited evidence

    A 2019 meta-analysis of 10 RCTs (577 participants) found no effect on total cholesterol (WMD -1.04 mg/dL), LDL (-1.96 mg/dL), HDL (+0.16 mg/dL), triglycerides (+0.69 mg/dL), systolic BP (-0.85 mmHg) or diastolic BP (-0.48 mmHg), with low heterogeneity. A larger 2025 meta-analysis with more trials did report significant reductions in fasting glucose, triglycerides, total cholesterol, LDL, systolic BP and TNF-alpha — but only in subgroups above 500 mg/day and beyond 12 weeks, and with no effect on insulin, HOMA-IR, HDL, diastolic BP or hs-CRP. The honest read: small, dose- and duration-dependent, not robust.

  • Its vein-health reputation is borrowed from combination products Limited evidence

    Hesperidin appears as hesperidin methyl chalcone in the Ruscus combination Cyclo 3 Fort and as the 10% minor fraction of micronized purified flavonoid fraction alongside diosmin. Both formulas have decent trial data — but no trial isolates hesperidin's contribution, and standalone hesperidin capsules have never been tested for venous insufficiency or hemorrhoids at the doses those formulas deliver.

  • Bioavailability is the bottleneck, and modified forms absorb better Moderate evidence

    Hesperidin is a rutinoside that human intestinal enzymes cannot cleave; it must first be hydrolysed by colonic bacteria, making absorption low and highly variable between individuals — some people are effectively non-responders. Enzymatically modified glucosyl-hesperidin (G-hesperidin) reaches roughly three times higher plasma levels, but no trial has shown that this translates into better clinical outcomes, so paying a premium for it is a bet on pharmacokinetics, not results.

Dosage & safety

Studied doseTrials used 292-1000 mg/day, most commonly 500 mg/day for 3-12 weeks; the subgroup signals in the 2025 meta-analysis appeared above 500 mg/day and beyond 12 weeks. For reference, 250 mL of orange juice supplies roughly 40-60 mg hesperidin, so supplement doses are 10-20x dietary intake.
SafetyWell tolerated in trials; occasional GI upset and headache. Citrus flavonoids inhibit CYP enzymes and OATP transporters in laboratory systems — the clinical relevance at supplement doses is unclear, but use caution with narrow-therapeutic-index drugs (warfarin, certain statins, immunosuppressants) and ask a pharmacist. Mild antiplatelet effects have been reported in vitro; stop before surgery. Not established in pregnancy or breastfeeding at supplemental doses. No long-term safety data beyond a few months. Not banned in sport.

Scientific references

Where to buy

Nature's Craft, Diosmin & Hesperidin, 60 Capsules

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Heart & metabolic